EMA (EU)
EVENT
First European Medicines Agency (EMA) - International Society for Cell and Gene Therapy (ISCT) bilateral meeting
Published: 10/12/2026Detected: 9/22/2026
Summary preview
Facilitates an EMA bilateral dialogue with the ISCT to exchange views on topics of common interest, with a focus on how industry and regulators coordinate on cell and gene therapy matters.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountOfficial Source Document Source Verified
Access the original document directly from EMA.
More from EMA (EU)
- Pharmacovigilance Risk Assessment Committee (PRAC): 23 - 26 November 202611/23/2026
- Seventeenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines11/20/2026
- EMA annual call with General Practitioner Organisations' representatives11/20/2026
- Digitalisation and artificial intelligence in pharmaceutical manufacturing: Quality Innovation Group (QIG) - Follow-up roundtable meeting11/18/2026
- Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - November 202611/18/2026